Literature DB >> 8774301

Serial laparoscopies over 30 months show that endometriosis in captive baboons (Papio anubis, Papio cynocephalus) is a progressive disease.

T M D'Hooghe1, C S Bambra, B M Raeymaekers, P R Koninckx.   

Abstract

OBJECTIVE: To test the hypothesis that spontaneous endometriosis is a progressive disease in baboons. DESIGN AND
SETTING: Prospective cohort study, Institute of Primate Research, Nairobi, Kenya. PARTICIPANTS: Twelve baboons with histologically proven spontaneous endometriosis.
INTERVENTIONS: Fifty-four serial laparoscopies (4.2 +/- 1.9 per animal, range 1 to 7) were performed after 1 to 3 months (n = 2), 4 to 6 months (n = 1), 7 to 9 months (n = 6), 10 to 12 months (n = 17), 13 to 15 months (n = 7), 16 to 18 months (n = 1), 19 to 21 months (n = 8), 22 to 24 months (n = 8), 25 to 27 months (n = 2), and 30 to 32 months (n = 2). MAIN OUTCOME MEASURE: During each laparoscopy the pelvis was examined for the presence of endometriosis. The number, size, and type of endometriotic implants were noted on a pelvic map and both endometriosis score and stage were calculated. Remodeling was defined as a change in laparoscopic appearance (typical, subtle, suspicious) of an individual endometriotic lesion. Data were analyzed by a signed rank test.
RESULTS: Endometriosis was progressive as shown by the significant increase in the number and surface of lesions and in endometriosis scores after 24 months. The total number of endometriotic lesions after 24 months consisted of 69% new (and mostly subtle) implants, 10% remodeled lesions, and 21% unchanged implants.
CONCLUSIONS: This study demonstrated that endometriosis in captive baboons undergoing repeated laparoscopies is a dynamic and moderately progressive disease with periods of development and regression and active remodeling between different types of lesions.

Entities:  

Mesh:

Year:  1996        PMID: 8774301

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Lesion kinetics in a non-human primate model of endometriosis.

Authors:  P Harirchian; I Gashaw; S T Lipskind; A G Braundmeier; J M Hastings; M R Olson; A T Fazleabas
Journal:  Hum Reprod       Date:  2012-06-06       Impact factor: 6.918

2.  Aberrant gene expression profile in a mouse model of endometriosis mirrors that observed in women.

Authors:  Katherine E Pelch; Amy L Schroder; Paul A Kimball; Kathy L Sharpe-Timms; J Wade Davis; Susan C Nagel
Journal:  Fertil Steril       Date:  2009-05-26       Impact factor: 7.329

3.  Cellular Changes Consistent With Epithelial-Mesenchymal Transition and Fibroblast-to-Myofibroblast Transdifferentiation in the Progression of Experimental Endometriosis in Baboons.

Authors:  Qi Zhang; Jie Duan; Mark Olson; Asgerally Fazleabas; Sun-Wei Guo
Journal:  Reprod Sci       Date:  2016-04-12       Impact factor: 3.060

4.  Pleuro-pulmonary endometriosis in baboons (Papio spp.): insights into pathogenesis.

Authors:  J Jagirdar; D Sirohi; E J Dick; G Hubbard
Journal:  J Med Primatol       Date:  2012-12-01       Impact factor: 0.667

5.  Long-term follow-up of a controlled trial of laser laparoscopy for pelvic pain.

Authors:  K D Jones; P Haines; C J Sutton
Journal:  JSLS       Date:  2001 Apr-Jun       Impact factor: 2.172

Review 6.  A baboon model for endometriosis: implications for fertility.

Authors:  Julie M Hastings; Asgerally T Fazleabas
Journal:  Reprod Biol Endocrinol       Date:  2006       Impact factor: 5.211

7.  Spontaneous endometriosis in cynomolgus monkeys as a clinically relevant experimental model.

Authors:  A Nishimoto-Kakiuchi; S Netsu; S Okabayashi; K Taniguchi; H Tanimura; A Kato; M Suzuki; T Sankai; R Konno
Journal:  Hum Reprod       Date:  2018-07-01       Impact factor: 6.918

8.  Endometriosis and its global research architecture: an in-depth density-equalizing mapping analysis.

Authors:  Dörthe Brüggmann; Alexandra Elizabeth-Martinez; Doris Klingelhöfer; David Quarcoo; Jenny M Jaque; David A Groneberg
Journal:  BMC Womens Health       Date:  2016-09-21       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.